// App-Quantinova.ai

AEP472 : AKR1D1 regulates androgen availability in vitro by generating metabolites that are unable to activate the androgen receptor

Researchers

Presenter

  • Elena Gangitano

Principal Investigators

  • Karl Storbeck

  • Nikolaos Nikolaou

  • Jeremy Tomlinson

Medical Centers

  • University of Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford, United Kingdom

  • Sapienza University of Rome, Dept. Experimental Medicine, Roma, Italy, Italy

  • Stellenbosch University, Department of Biochemistry, Stellenbosch, South Africa

Locations

  • United Kingdom

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Testosterone

Drug/Treatment

  • Dihydrotestosterone

  • Androgen Tear

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved